<DOC>
	<DOCNO>NCT01419067</DOCNO>
	<brief_summary>The goal study determine feasibility safety treat patient brain tumor know craniopharyngioma limit surgery 5mm clinical target volume margin combination proton therapy . Proton therapy indicate patient diagnosed craniopharyngioma treat radical surgery ( gross-total resection ) . Irradiated patient undergo series evaluation design evaluate effect proton therapy . Similar evaluation perform patient treated radical surgery . Proton therapy include 30 treatment fraction administer 5 day per week . Weekly image requirement monitor cyst expansion target volume deformation .</brief_summary>
	<brief_title>A Phase II Trial Limited Surgery Proton Therapy Craniopharyngioma Observation After Radical Resection</brief_title>
	<detailed_description>The primary objective study : To estimate progression-free overall survival distribution child young adult craniopharyngioma treat limited surgery proton therapy use 5mm clinical target volume margin monitor excessive central nervous system necrosis . The Secondary Objectives study : - To estimate cumulative incidence cystic intervention event-free survival distribution child young adult craniopharyngioma treat limited surgery proton therapy use 5mm clinical target volume margin ; compare distribution progression-free , event-free overall survival distribution St. Jude Children 's Research Hospital cohort 93 patient design trial base . - To estimate distribution progression-free survival overall survival child young adult craniopharyngioma treated primary surgical resection compare distribution distribution observe patient treat limited surgery proton therapy .</detailed_description>
	<mesh_term>Craniopharyngioma</mesh_term>
	<mesh_term>Adamantinoma</mesh_term>
	<criteria>Craniopharyngioma diagnose histology , cytology neuroimaging . Patients age 021 year time diagnosis . Exclusion Criteria Prior history fractionate radiation therapy . Prior treatment intracystic P32 , intracystic bleomycin radiosurgery . Pregnant female exclude . Radiation teratogenic abortifacient effect .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Proton Therapy</keyword>
	<keyword>Radical resection</keyword>
</DOC>